JSPR

AS OF

Nov 11, 04:15 PM (EDT)

Price

$14.75Alerts

Change

-$0.00 (-0.00%)

Capitalization

561.01M

118 days until earnings call

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

+Compare

JSPR

Stock ticker: NASDAQ

AS OF

Nov 11, 04:15 PM (EDT)

Price

$14.75

Change

-$0.00 (-0.00%)

Capitalization

561.01M

JSPR

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Jasper Therapeutics (JSPR) Ownership - Who owns Jasper Therapeutics?

Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma... Show more

Get AI intraday alerts

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

2200 Bridge Parkway

Phone

+1 650 549-1400

Employees

Web

https://www.jaspertherapeutics.com

Details

Group

Domestic Stock Funds

AIM ImmunoTech (AIM): A Clinical-Stage Biotech Centered on Ampligen for Pancreatic Cancer

AXON

AXON vs SEER: Weighing a Public Safety Leader Against a Cash-Rich Life Sciences Play

XTLB

XTL Biopharmaceuticals (XTLB): Psychedelic Pivot Meets Nasdaq Compliance Challenges

ARCT

Arcturus Therapeutics (ARCT) Delivers Q3 Beat as Pipeline Momentum Builds

INSM

ENGN vs INSM: Weighing a Clinical-Stage Developer Against a Commercial Biopharma

View all blogs related to
#Biotechnology

Interesting Articles

What is the highest-paid occupation in the US?

What is a Run Rate?

How is Ripple Different Than Bitcoin and Ethereum?

Mutual Fund vs. ETF: What's the Difference?

What Is Insider Trading, and Is It Always Illegal?

View all articles

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Industry

N/A

Address

2200 Bridge Parkway

Phone

+1 650 549-1400

Employees

Web

https://www.jaspertherapeutics.com